Ivax CFC-Free Albuterol Will Launch In Fourth Quarter
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA cleared the NDA for the asthma treatment Oct. 29. Ivax’ CFC-free albuterol inhaler offers an alternative to GlaxoSmithKline’s Ventolin HFA in advance of an FDA final rule that is expected to remove CFC-propelled albuterol from the market in 2006.